Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
Novo Nordisk CEO Lars Jorgensen testifies to the Senate of Health, Education, Labor and pensions that listen to US weight loss drugs Ozempic and Wegovy, on the Capitol Hill in Washington, USA, September 24, 2024.
Pirashka van de Wuy | Reuters
The CEO of Novo Nordisk Lars Fruergaard Jørgensen leaves the post, the manufacturer Wegovy said on Friday, citing recent market problems.
The Danish Pharmaceutical Giant said Frugard Jorgensen would remain in his post “over a period to support the unobstructed transition to the new leadership.”
This is amazing news, please check the updates.
